Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03530449 · ClinicalTrials.gov registry record
Evaluation of the Repeatability and Reproducibility of OCTA Image Quality With the Heidelberg Engineering SPECTRALIS With OCT Angiography Module
A clinical trial, sponsored by Heidelberg Engineering.
- Terminated
- Registry status
- 39
- Enrollment target
NCT03530449: Clinical Trial study, sponsored by Heidelberg Engineering.
NCT03530449 is a clinical trial that was terminated before completion, run by Heidelberg Engineering. The registered enrollment target is 39 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03530449 was terminated before completion, sponsored by Heidelberg Engineering.
- TERMINATED
- Registry status
- 39 participants
- Enrollment target
Study Summary
Repeatability and Reproducibility of OCTA Image Quality with the Heidelberg Engineering SPECTRALIS
Primary Outcome
Image quality grading results of study selected images
Interventions
- DEVICE Optical Coherence Tomography
- DEVICE OCT Angiography
- DEVICE Color Fundus Photography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2018-04-30 |
| Est. Completion | 2018-09-15 |
Why NCT03530449 stopped before completion
NCT03530449 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 39 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Optical Coherence Tomography is the first listed.
NCT03530449 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03530449 about?
NCT03530449 is a clinical study titled "Evaluation of the Repeatability and Reproducibility of OCTA Image Quality With the Heidelberg Engineering SPECTRALIS With OCT Angiography Module". Repeatability and Reproducibility of OCTA Image Quality with the Heidelberg Engineering SPECTRALIS
What is the current status of trial NCT03530449?
This trial is currently terminated. The enrollment target is 39 participants. The study started on 2018-04-30. Estimated completion is 2018-09-15.
What interventions are being tested in trial NCT03530449?
The interventions under investigation include: Optical Coherence Tomography (DEVICE), OCT Angiography (DEVICE), Color Fundus Photography (DEVICE).
Who is sponsoring clinical trial NCT03530449?
This trial is sponsored by Heidelberg Engineering, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI